Serranator POINT FORCE Registry
Recruiting
- Conditions
- Peripheral Artery Disease (PAD)Dysfunctional AV FistulaDysfunctional AV Graft
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Cagent Vascular LLC
- Target Recruit Count
- 500
- Registration Number
- NCT06687590
- Locations
- 🇺🇸
UT Southwestern, Dallas, Texas, United States
Serrantor OCT Study
Not Applicable
Recruiting
- Conditions
- Critical Limb Ischemia
- Interventions
- Device: Serranator PTA Serration CatheterDrug: PTA (Standard of Care)
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Cagent Vascular LLC
- Target Recruit Count
- 60
- Registration Number
- NCT06434194
- Locations
- 🇺🇸
Columbia University, New York, New York, United States
🇺🇸Weill Cornell Medical, New York, New York, United States
Serranator Recoil Study
Not Applicable
- Conditions
- Critical Limb IschemiaPeripheral Arterial Disease
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2022-06-09
- Lead Sponsor
- Cagent Vascular LLC
- Target Recruit Count
- 20
- Registration Number
- NCT05161039
- Locations
- 🇺🇸
Stanford University, Palo Alto, California, United States
🇩🇪Klinik für Angiologie, Klinikum Hochsauerland GmbH, Arnsberg, Germany
The PRELUDE BTK Study
Not Applicable
Completed
- Conditions
- Critical Limb IschemiaPeripheral Arterial Disease
- First Posted Date
- 2018-10-03
- Last Posted Date
- 2021-01-28
- Lead Sponsor
- Cagent Vascular LLC
- Target Recruit Count
- 49
- Registration Number
- NCT03693963
- Locations
- 🇦🇹
Medical University of Graz, Graz, Austria
🇩🇪Klinikum Hochsauerland GmbH, Arnsberg, Germany
🇩🇪Krankenhaus Buchholz, Buchholz, Germany
Serranator® Alto Post Market Clinical Follow Up (PMCF) Study
Withdrawn
- Conditions
- Arterio-venous FistulaPeripheral Arterial DiseaseArteriovenous Graft
- First Posted Date
- 2018-05-29
- Last Posted Date
- 2020-04-10
- Lead Sponsor
- Cagent Vascular LLC
- Registration Number
- NCT03538392
PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE
Not Applicable
Completed
- Conditions
- Peripheral Arterial Disease
- First Posted Date
- 2016-12-23
- Last Posted Date
- 2018-04-24
- Lead Sponsor
- Cagent Vascular LLC
- Target Recruit Count
- 25
- Registration Number
- NCT03001700
- Locations
- 🇦🇹
Medizinische Universtität Graz, Graz, Austria
🇳🇿Auckland City Hospital, Auckland, Grafton, New Zealand
🇵🇱Polsko-Amerykańskie Kliniki Serca PAKS Małopolskie Centrum Sercowo Naczyniowe, Chrzanow, Poland